ICC Cricket World Cup 2019: Pak TV channel uses Abhinandan spoof ahead of India clash

New Delhi, Jun 13: Five centrally contracted Indian cricketers including Cheteshwar Pujara, Ravindra Jadeja and KL Rahul have been issued notices by National Anti-Doping Agency (NADA) for failing to disclose their whereabouts as the BCCI cited "password glitch" as the reason for delay.

The other players to have received the notice include women stars Smriti Mandhana and Deepti Sharma, who are among the five cricketers in the 110 strong National Registered Testing Pool (NRTP). Speaking to PTI, NADA DG Navin Agarwal confirmed that BCCI has sent an official explanation for their five NRTP players' failure to submit whereabouts.

"There are two ways to fill up the whereabouts form in the ADAMS (Anti Doping Administration & Management Systems) software. Either athlete does it himself or association fills it up on his or her behalf," Agarwal said. "Now athletes in some discipline aren't educated enough or do not have access to internet and find themselves unable to handle the whereabouts clause of the ADAMS or upload the filled up

"They use assistance of their concerned federations. So federations have accepted responsibility of uploading their whereabouts," Agarwal said.

He said cricketers too at times find it tough to complete the process on their own. "Similarly in cricket also, although these people are well qualified and they can do it, perhaps they don't have the time for whatever reasons, so the federation concerned, the BCCI has taken upon itself the responsibility of uploading their whereabouts." So why didnt BCCI upload the the three-month whereabouts this time?

"Well they have given an explanation which appears to be reasonable but a decision will be taken. They have said that there has been a glitch with regards to password in ADAMS. Now they have said that issue has been resolved," Agarwal added. NADA DG added that "BCCI's explanation will be discussed as to whether it will be counted as one of three filing failures or not. It will be decided on the explanation given and how they (BCCI) proceed from here."

While country has been under lockdown, the rule to submit three months of whereabouts is mandatory. Three such failures to disclose leads to one Anti Doping Rule Violation (ADRV), which could lead up to two years of suspension upon hearing.

While BCCI has "officially gagged" its employees from talking to the media, it couldn't be ascertained that why as normal a glitch as a password error took days to resolve. A BCCI veteran, who has been privy to cricket operations, asked why the five cricketers were not told to upload the form themselves.

"This was lockdown period where they are not living out of suitcases. Some of the names have also engaged in multiple instagram chats and podcasts which their agents are managing," he said.

"If cricket operations team were having a glitch in fixing password, well the five cricketers could have been asked to do so and they would have done it individually with some guidance. "Probably NADA would be lenient this time but if it becomes an official warning, then who's responsible," he added.

New Delhi, Jun 2: Manchester United's Paul Pogba on Monday paid tribute to George Floyd, stressing that violent acts of racism can no longer be tolerated and they have to stop.

Pogba took to Instagram to write: "During the past few days I have thought a lot about how to express my feelings about what happened in Minneapolis. I felt anger, pity, hatred, indignation, pain, sadness."

"Sadness for George and for all black people who suffer from racism Every day! Whether in football, at work, at school, Anywhere! This has to stop, once and for all! Not tomorrow or the next day, it has to end today! Violent acts of racism can no longer be tolerated," he added.

Protests erupted in Minneapolis and other US cities on Tuesday after Floyd, an African-American man, died following his arrest by the four officers.

A viral video showed a police officer, Derek Chauvin, pinning 46-year-old Floyd to the ground with his knee on his neck for nearly eight minutes. Floyd died at a local hospital shortly thereafter.

The four police officers were fired. Chauvin was also charged with murder and manslaughter, according to Hennepin County Attorney Mike Freeman.

Beijing/Zurich, Mar 4: China has approved the use of Swiss drugmaker Roche's anti-inflammation drug Actemra for patients who develop severe complications from the coronavirus as it urgently hunts for new ways to combat the deadly infection that is spreading worldwide.

China is hoping that some older drugs could stop severe cytokine release syndrome (CRS), or cytokine storms, an overreaction of the immune system which is considered a major factor behind catastrophic organ failure and death in some coronavirus patients.

Actemra, a biologic drug approved in 2010 in the United States for rheumatoid arthritis (RA), inhibits high Interleukin 6 (IL-6) protein levels that drive some inflammatory diseases.

China's National Health Commission said in treatment guidelines published online on Wednesday that Actemra can now be used to treat coronavirus patients with serious lung damage and high IL-6 levels.

Separately, researchers in the country are testing Actemra, known generically as tocilizumab, in a clinical trial expected to include 188 coronavirus patients and running until May 10.

Roche, which donated 14 million yuan ($2.02 million) worth of Actemra during February, said the trial was initiated independently by a third party with the aim of exploring the efficacy and safety of the drug in coronavirus patients with CRS.

It added that there was currently no published clinical trial data on the drug's safety or efficacy against the virus.

More than 3,000 people have died and 93,000 have been infected by the novel coronavirus thought to have originated in Wuhan, China, before spreading to around 90 countries including the United States, Italy, Switzerland, France and Germany.

The Swiss company, for which China is its No. 2 market behind the United States, also makes diagnostic gear to detect the coronavirus.

Since Actemra's approval a decade ago, it has become a go-to drug against other inflammatory conditions, including cytokine storms in cancer patients receiving cell therapies from Novartis and Gilead Sciences.

In 2012 it helped save the life of a young U.S. girl, the first child to be treated for leukaemia with Novatis' Kymriah, from a post-treatment rush of IL-6.

Priced at between $20-30,000 annually for RA according to SSR Health, Roche's medicine is also used for rare juvenile arthritis and giant cell arteritis, or inflammation of the blood vessels.